2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Sunday, April 30, 2017

5:30pm-5:42pm: Poor Outcomes on the Waiting List for Pediatric Lung Retransplant Patients Listed in Low Volume Centers.

B. Scully,¹ J. Heinle,¹ M. Kueht,¹ E. McKenzie,¹ G. Mallory,² E. Melicoff,² A. Rana.¹

Concurrent Session: Lung Transplantation from Donation to Retransplantation • E270

5:30pm-5:42pm: Rapamycin Directly Alters Human Endothelial Cell Alloimmunogenicity.

V. Bendersky,¹ H. Xu,² A. Kirk.²

Concurrent Session: Pathways of Clinical Rejection • E351

5:30pm-5:42pm: Reduction in Kidney Offer Acceptance at Centers Undergoing Systems Improvement Agreements.

M. Bowring, L. Nicholas, A. Massie, D. Segev.

Concurrent Session: Kidney Allocation: Changes and Consequences • E450a

5:30pm-5:42pm: T_FR:T_FH Cell Ratio Correlates with Anti-Donor Germinal Center Reactivity and Donor-Specific Antibody Formation Following Transplantation.

G. La Muraglia II, M. Ford, I. Badell.

Concurrent Session: T Cell Biology and Alloimmunity • E352

5:30pm-5:42pm: The Innate Immune-System May Play an Enhanced Role in Acute Cellular Rejection in Patients on Belatacept-Based Immunosuppression.

D. Dobi,¹ Q. Tang,² S. Chandran,³ F. Vincenti,³ Z. Laszik.¹

Concurrent Session: Kidney: Acute Cellular Rejection • E451b

5:30pm-5:42pm: The Role of Natural Killer Cells in Recognition and Killing of Stem Cells and Stem Cell-Derived Hepatoblasts.

T. Cisneros, D. Dillard, M. Castro, J. Arredondo-Guerrero, S. Krams, C. Esquivel, O. Martinez.

Concurrent Session: Innate Immunity • E350

5:42pm-5:54pm: A Low-Dose Anti-Hepatitis B Immunoglobulin Regimen for Prophylaxis of Hepatitis B Recurrence.

W.-C. Lee, Y.-C. Wang, C.-H. Cheng, T.-H. Wu, C.-F. Lee, T.-J. Wu, H.-S. Chou, K.-M. Chan.

Concurrent Session: Liver: Viral Hepatitis • E271a

5:42pm-5:54pm: Applicability and Safety of a Regulatory T Cell Therapy in Adult Liver Transplantation: The “ThRIL” Phase I First-in-Human Trial.

G. Whitehouse, N. Safinia, S. Thirkell, L. Fry, N. Grageda, M. Martinez-Llordella, R. Lechler, N. Heaton, G. Lombardi, A. Sanchez-Fueyo.

Concurrent Session: Tolerance: Clinical Studies • E353C

5:42pm-5:54pm: Characterization of Human Plasma Cell Proteasome Adaptations to Proteasome Inhibitor Therapy: A Precision Medicine Approach to Overcome Drug Resistance in Desensitization.

J. Driscoll,¹ S. Tremblay,¹ P. Brailey,¹ A. Girnita,¹ R. Alloway,¹ B. Aronow,² H. Singh,² E. Woodle.²

Concurrent Session: Clinical Science: Kidney Immunosuppression: Desensitization • E354b

5:42pm-5:54pm: Genomic Analysis of Gene Expression in Human Kidney Transplants Identifies Moxd1 as a Key Driver for Renal Fibrosis.

C. Wei,¹ M. Menon,¹ W. Zhang,¹ C. Woytovich,¹ N. Philippe,¹ J. He,^1,2 B. Murphy,¹ C. Wei.

Concurrent Session: Pathways of Clinical Rejection • E351